You just read:

Impel NeuroPharma Announces Publication Of Narrative Review In The Journal Headache Supporting Need For Novel Formulations Of Dihydroergotamine (DHE) In Addressing Acute Treatment Of Migraine

News provided by

Impel NeuroPharma

Nov 20, 2019, 11:49 ET